Company News: Boehringer Ingelheim

Share this article:
The Boehringer Ingelheim-backed Drive4COPD awareness campaign is getting a big response through its use of social media, the company said. The campaign, which launched two weeks ago, has generated 27,000 completions of a validated five-question screener available at Drive4COPD.com, along with 1,400 Facebook fans, 25,000 clicks on campaign images at photo sharing site Flickr, 140,000 search results and 14,500 Twitter followers who've been exposed to some 50 Tweets from the campaign's celebrity ambassadors.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.